The blood–brain barriers: novel nanocarriers for central nervous system diseases
Abstract The central nervous system (CNS) diseases are major contributors to death and disability worldwide. However, the blood–brain barrier (BBB) often prevents drugs intended for CNS diseases from effectively crossing into the brain parenchyma to deliver their therapeutic effects. The blood–brain...
Saved in:
| Main Authors: | Jiajun Liu, Ting Wang, Jian Dong, Yuan Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-025-03247-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases
by: Yi Qiu, et al.
Published: (2025-06-01) -
The effects of inflammation on blood-brain barrier permeability and the ability of cancer nanomedicine to cross the blood-brain barrier.
by: Michelle Zhou
Published: (2024-08-01) -
PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier
by: Anikó Szecskó, et al.
Published: (2025-04-01) -
Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles
by: Yuan Zou, et al.
Published: (2025-03-01) -
Effects of M. tuberculosis and HIV-1 infection on in vitro blood-brain barrier function
by: Alizé Proust, et al.
Published: (2025-05-01)